Novo Nordisk A/S reported the third fire in a bit over a month at its Danish facilities, this time at an office building it had rented near its headquarters.
Belk Seeks $500 Million in Fresh Financing With Help from KKRWall Street Faces Tougher Margin Rule as Zero-Day Options BoomAQR Hails Comeback of Convertible Arbitrage in Era of High RatesEuropean Stocks Rebound as Dust Settles From Macron Vote CallPrivate Companies’ Profits Outpace Public Firms, Fed Study ShowsA Waste-Oil Crunch Is Coming for World’s Renewable FuelmakersSteve Cohen’s Point72 Readies New Hedge Fund Targeting AI StocksHSBC’s Private Bank Violated Money Laundering Rules, Finma...
5 Billion of LoansA Waste-Oil Crunch Is Coming for World’s Renewable FuelmakersRobots and Specialized Software Open New Solar Farm Development OpportunitiesSweden’s Nuclear Power Goal is Challenging But AttainableTexas, Mexico Prepare for Possible Tropical Storm: Weather WatchEU Black Sea Wheat Cheaper Than Rivals’ Due to Bumper HarvestsFrench Power Languishes at Record Discount to German PriceA Trump Win Puts $369 Billion in Clean Energy Incentives at Risk, BI SaysOil price news: Oil holds...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ozempic Maker Novo Nordisk Halts Roof Repairs for Probe After Factory FireNovo Nordisk A/S has halted roof repairs across its sites as it investigates last week’s fire at the Danish manufacturing hub where it makes the key ingredient for its blockbuster weight-loss drug.
Read more »
Novo Nordisk Fire Extinguished at Danish Headquarters ComplexA fire at a Novo Nordisk A/S office building has been put out at the Danish headquarters complex, in what was the second blaze to hit the drugmaker in less than a week.
Read more »
Novo’s Ozempic Slashes Risk of Death in Kidney Disease StudyNovo Nordisk A/S’s blockbuster diabetes drug Ozempic cut patients’ risk of dying in a kidney-disease study, the latest research pointing to the medicine’s usefulness in a constellation of disorders.
Read more »
Eli Lilly and Novo Nordisk are a 'duopoly' in GLP-1 marketGLP-1 weight-loss drugs have been major revenue generators for pharmaceutical companies such as Eli Lilly (LLY) and Novo Nordisk (NVO). Goldman Sachs US Lead...
Read more »
Novo Nordisk Threatens Lego’s Position as Denmark’s No. 1 BrandDenmark’s Lego A/S has long reigned as the country’s most valuable brand, but the toymaker is now under threat of being toppled by Novo Nordisk A/S, whose weight-loss treatments have become a global pop culture phenomenon.
Read more »
Wegovy maker Novo Nordisk sues nine spas, clinics and pharmacies over copycat drugsExplore stories from Atlantic Canada.
Read more »